In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.

about

Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureus Evolving clinical microbiology in the Armed Forces Laboratories for rapid detection of antimicrobial resistant bugs and emerging viruses.

P2860

Q41843806-A313FEBD-B8A4-4B10-9783-3ADA4F828418 Q42123259-31C14B23-7D8D-4D0F-B371-DA268F976C76

P2860

In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.

Item

http://www.wikidata.org/entity/Q41672254

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.

@en

type

Item

label

In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.

@en

prefLabel

In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.

@en

P1476

In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus

@en

P2093

A K Prahraj

http://www.w3.org/2001/XMLSchema#string

A K Sahni

http://www.w3.org/2001/XMLSchema#string

K Tandel

http://www.w3.org/2001/XMLSchema#string

N Grover

http://www.w3.org/2001/XMLSchema#string

P Bhatt

http://www.w3.org/2001/XMLSchema#string

P2860

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence.

Is vancomycin MIC creep a worldwide phenomenon? Assessment of S. aureus vancomycin MIC in a tertiary university hospital

Methicillin-resistant Staphylococcus aureus: prevalence and current susceptibility pattern in sikkim

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.

Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern.

Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad.

Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus.

P304

215-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MJAFI.2013.11.008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sourav Sen

C N Chaudhari

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260609864

http://www.w3.org/2001/XMLSchema#string

P698

25378772

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

4213919

http://www.w3.org/2001/XMLSchema#string

In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.

about

P2860

P2860

In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932